Trans-ancestry mutational landscape of hepatocellular carcinoma genomesYasushi Totoki, Tatsuhiro Shibata, Kenji Tatsuno et al.|Nature Genetics|2014Cited by 780
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaMasatoshi Kudo, Kiwamu Okita, Dong Jin Suh et al.|European Journal of Cancer|2011Cited by 573
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON studyJorge A. Marrero, Riccardo Lencioni, Masatoshi Kudo et al.|Journal of Hepatology|2016Cited by 385
Phase I Trial of a Glypican-3–Derived Peptide Vaccine for Advanced Hepatocellular Carcinoma: Immunologic Evidence and Potential for Improving Overall SurvivalYu Sawada, Tetsuya Nakatsura, Toshiaki Yoshikawa et al.|Clinical Cancer Research|2012Cited by 299
Virologic Analysis of Non‐B, Non‐C Hepatocellular Carcinoma in Japan: Frequent Involvement of Hepatitis B VirusHiroshi Yotsuyanagi, Kazuhiko Koike, Yoshizumi Shintani et al.|The Journal of Infectious Diseases|2000Cited by 99